Adcetris

Active substance

Brentuximab vedotin

Holder

Takeda Belgium

Status

Closed

Indication

in combination with cyclophosphamide, doxorubicin and prednisone (CHP) for the treatment of adult patients with previously untreated systemic anaplastic cell lymphoma (sALCL)

Public documents

Approbation

Approbation amendment

Information for the patient

Informed consent

Last update

01/04/2021

Last updated on 13/02/2024